Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 32Leukemia 26Melanoma 25Kidney Neoplasms 25Leukemia, Myeloid, Chronic-Phase 22Multiple Myeloma 17Lymphoma 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Neoplasms, Plasma Cell 13Lymphoma, Follicular 12Pancreatic Neoplasms 9Lymphoma, Mantle-Cell 8Leukemia, Lymphocytic, Chronic, B-Cell 8Waldenstrom Macroglobulinemia 7Neoplasms 7Lymphoma, Non-Hodgkin 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Myeloid, Acute 7Burkitt Lymphoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Accelerated Phase 6Carcinoma, Hepatocellular 6Colorectal Neoplasms 5Urinary Bladder Neoplasms 4Recurrence 4Rectal Neoplasms 4Lung Neoplasms 4Immunoglobulin Light-chain Amyloidosis 4

Interventions

Gemcitabine 25Cisplatin 18Carboplatin 10Paclitaxel 9Specimen Handling 6Nivolumab 6Doxorubicin 6Docetaxel 6pembrolizumab 5Magnetic Resonance Spectroscopy 5cabozantinib 4avelumab 4Vinblastine 4Radiotherapy 4Methotrexate 4Fluorouracil 4enfortumab vedotin 3atezolizumab 3aflibercept 3Trastuzumab 3Sunitinib 3Ramucirumab 3Platinum 3Ipilimumab 3Immunoglobulin G 3Disulfides 3CTLA-4 Antigen 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3vinflunine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urethral Neoplasms × Interferon-alpha × Clear all
NCT00082719 2015-05-14

Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium

M.D. Anderson Cancer Center

Phase 1 Completed
33 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡